Flavonoids are phytochemicals present in almost all terrestrial plants and, as a consequence, in plant-based foods, and thus consumed by humans through diet. Recent evidences suggest that several flavonoids have positive effects against dementia and Alzheimer’s disease, reversing age-related declines in neurocognitive performances. In this review, we provide a general classification of natural and synthetic flavonoids, a description of their physico-chemical properties, in particular their redox properties and stability, and an extensive overview about their biological activities and structure-activity relationship in the field of neurodegenerative diseases. In addition, a section will be dedicated to the synthetic strategies for the preparation of bioactive derivatives. This information will be essential for the design and development of new drugs that can improve brain functions.
Flavonoids in the treatment of Alzheimer’s and other neurodegenerative diseases / C. Airoldi, B. La Ferla, G. D'Orazio, C. Ciaramelli, A. Palmioli. - In: CURRENT MEDICINAL CHEMISTRY. - ISSN 0929-8673. - 25:27(2018), pp. 3228-3246. [10.2174/0929867325666180209132125]
Flavonoids in the treatment of Alzheimer’s and other neurodegenerative diseases
G. D'Orazio;
2018
Abstract
Flavonoids are phytochemicals present in almost all terrestrial plants and, as a consequence, in plant-based foods, and thus consumed by humans through diet. Recent evidences suggest that several flavonoids have positive effects against dementia and Alzheimer’s disease, reversing age-related declines in neurocognitive performances. In this review, we provide a general classification of natural and synthetic flavonoids, a description of their physico-chemical properties, in particular their redox properties and stability, and an extensive overview about their biological activities and structure-activity relationship in the field of neurodegenerative diseases. In addition, a section will be dedicated to the synthetic strategies for the preparation of bioactive derivatives. This information will be essential for the design and development of new drugs that can improve brain functions.| File | Dimensione | Formato | |
|---|---|---|---|
|
0004C.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.19 MB
Formato
Adobe PDF
|
1.19 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
14_Flavonoids+in+the+Treatment+of+Alzheimer’s+and+Other+Neurodegen.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.05 MB
Formato
Adobe PDF
|
1.05 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




